The treatment proposal for the patients with breast diseases in the central epidemic area of 2019 coronavirus disease
10.3760/cma.j.cn112139-20200221-00116
- VernacularTitle: 新型冠状病毒肺炎疫情严重地区乳腺疾病患者的管理策略
- Author:
Lu ZHAO
1
;
Lin ZHANG
1
;
Jinwen LIU
1
;
Zhifang YANG
1
;
Wenzhuang SHEN
1
;
Xingrui LI
1
Author Information
1. Department of Thyroid and Breast Surgery of Tongji Hospital Affiliated with Tongji Medical College of Huazhong University of Science &Technology, Wuhan 430030, China
- Publication Type:Journal Article
- Keywords:
Coronavirus infected diseases;
Novel coronavirus pneumonia;
COVID-19;
Breast diseases
- From:
Chinese Journal of Surgery
2020;58(0):E005-E005
- CountryChina
- Language:Chinese
-
Abstract:
Currently, the epidemic of 2019 coronavirus disease (COVID-19) is still ongoing. The characteristics including high contagiousness, herd susceptibility and clinical phenotype diversity, made a serious influence on people’s daily life and rountine therapy for other diseases. Breast dieases are clinical common diseases. In the central epidemic area of COVID-19, Hubei province, especially Wuhan, the clinical specialists of breast diseases should consider all of the following factors comprehensively: the prevention of COVID-19, the diagnosis and treatment of breast diseases and the accessibility of medical resources. Besides, we should select the appropriate therapy and optimize treatment process so as to prevent the propagation and cross infection of COVID-19 as well as manage the breast diseases without delay. Therefore, we carried out some management proposals of the patients with breast diseases in the central epidemic area during the epidemic of COVID-19 on the basis of conventional treatment guidelines and clinical experiences. The suggestions and corrections from colleagues will be welcomed.
